Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

iAnthus Capital Holdings Inc. (C:IAN)

Business Focus: Medical Farming

Sector:  Healthcare Industry:  Healthcare Facilities & Services
Company Contact
Address: 420 Lexington Ave, Suite 414
Tel: N/A
IR: See website
Key People
Richard Proud
Chief Executive Officer, Director
Philippe Faraut
Chief Financial Officer
Business Overview
iAnthus Capital Holdings, Inc. is a vertically integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is also a developer, producer and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its subsidiaries, the Company owns and/or operates 35 dispensaries and 11 cultivation and/or processing facilities in nine United States. The Company's two geographical segments are Eastern Region and Western Region. The Eastern Region includes the Company's operations in Florida, Maryland, Massachusetts, New York, New Jersey, and Vermont. The Western Region includes the Company's operations in Arizona and Nevada as well as its assets and investments in Colorado. Its CBD products include topical creams, tinctures and sprays and products designed for beauty and skincare (such as lotions, creams, haircare products, lip balms and bath bombs).
Financial Overview
For the nine months ended 30 September 2023, iAnthus Capital Holdings Inc revenues decreased 6% to $118.4M. Net loss decreased 87% to $54.3M. Revenues reflect Western Region segment decrease of 18% to $41.3M, Other segment decrease of 73% to $227K. Lower net loss reflects Loss on debt extinguishment decrease of 100% to $1.3M (expense), Stock-based Compensation in SGA decrease of 92% to $2.2M (expense).
Reporting Currency: U.S. Dollars
Enterprise value: $342.82M as of Sep 30, 2023
Annual revenue (TTM): $210.21M as of Sep 30, 2023
EBITDA (TTM): -$15.97M as of Sep 30, 2023
Net annual income (TTM): -$132.18M as of Sep 30, 2023
Free cash flow (TTM): -$9.00M as of Sep 30, 2023
Net Debt Last Fiscal Year: $196.08M as of Sep 30, 2023
Shares outstanding: 6,553,687,248 as of Feb 7, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization